One of the reasons that S aureus and C diff present such a disinfection challenge is that they are encased in a biofilms such as yeast, protozoa, bacteria, fungi, and algae.
Cleaning and disinfecting hospital surfaces never ceases to be a vexing problem for infection preventionists (IPs), environmental services (EVS) crews, sterile processing teams, and just about any health care professional who cares about limiting the spread of infection in a hospital setting. Investigators with the University of Arizona found that Klorkleen 2 (KK2), an antibacterial surface coating, effectively limits the transmission of Staphylococcus aureus and Clostridium difficile in a laboratory setting.
Kelly Reynolds, PhD, lead author
“Higher bacterial reduction efficacies have been achieved in the current study with KK2 but application in real-world settings has yet to be evaluated,” states the study, which was published today in TIPS Journal. “The next steps are to evaluate product efficacy over time and under more realistic scenarios where surfaces are frequently touched, soil loads accumulate, and microbes are dried onto surfaces as part of the contamination and re-contamination cycle.”
Citing previous studies, investigators note that pathogen-filled hands can not only contaminate 51% of commonly touched surfaces but survive on those surfaces for days, weeks, or even months.
One of the reasons that S aureus and C diff present such a disinfection challenge is that they are encased in a biofilms such as yeast, protozoa, bacteria, fungi, and algae.
“Pathogen association with biofilm communities is a key survival factor in the environment that provides protection from biocides and enhances growth opportunities,” the TIPS Journal study states. “As biofilms mature, populations of cells may be firmly or weakly attached, allowing the biofilm to persist over time and to break off and be dispersed in the environment. Microbes, including multidrug-resistant organisms (MDRO), protected within biofilms are common and can persist on dry surfaces for months or longer.”
Again, citing earlier studies, the investigators with the University of Arizona posit that bleach-based disinfectants are often not up to the job. In addition, says the study, “many factors limit traditional cleaning and disinfecting efficacy including product and personnel issues (e.g., personnel shortages, training deficiencies)…. Common problems include widespread contamination, frequent recontamination, organic load interferences, missing contaminated surfaces during cleaning, poor adherence to manufacturer contact time guidelines, and more, which can increase pathogen exposure potentials.”
KK2, which is a continuously active disinfectant (CAD), was tested in Microchem Laboratory in Round Rock, Texas, which has been designated a good laboratory practice (GLP) by both the Environmental Protection Agency and the Food and Drug Administration.
“As reported by Microchem, test organisms were propagated in a liquid culture medium and suspended in nutrient broth,” the study states. “Carriers were treated with 0.5 mL of a 4,000 ppm solution of the CAD and allowed to air dry for 30 min in a laminar flow hood. Carriers were visibly dry before seeding. Untreated control and treated test surfaces (e.g., acrylic carriers, 50 mm x 50 mm) were inoculated with microbial seeds and covered with a thin, sterile film to facilitate even spreading of the inoculum, reduce evaporation, and ensure optimal contact with the antimicrobial surface.”
KK2 demonstrated sustained residual efficacy, the study states. Bacterial concentrations of S aureus were reduced below detectable levels. The bacterial were placed on a dry surface treated 30 minutes prior with the residual disinfectant. The initial control seed inocula ranged from 3.98 x 105 to 6.00 x 104.
“Increasing the initial seed concentration, therefore, might indicate an even greater log reduction efficacy potential for the intervention,” the study states. “Similarly, in two of the three timed scenarios with C. difficile, spore concentrations were reduced to below the limit of detection (5 CFU/carrier) from the initial control seed inocula, ranging from 1.50 x 105 to 4.45 x 105. C. difficile represents one of the more difficult surface contaminating pathogens in healthcare environments to inactivate using standard biocides.”
Investigators say that their results show that KK2 works well when it comes to reducing surface bacteria, including C. diff, which is infamously difficult to get rid of.
“CADs are considered a major discovery in the control of environmental contamination and infection spread,” the study states. “These antimicrobial coatings can be used passively in occupied rooms and continuously supplement manual cleaning to reduce the concentration of environmental pathogens.”
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.